Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 50 of 207

    1.

    Ferric Carboxymaltose in Patients with Heart Failure and Iron Deficiency.

    Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P; the FAIR-HF Trial Investigators.

    N Engl J Med. 2009 Nov 17. [Epub ahead of print]PMID: 19920054 [PubMed - as supplied by publisher]Related articlesFree article

    2.

    Bivalirudin in patients undergoing primary angioplasty for acute myocardial infarction (HORIZONS-AMI): 1-year results of a randomised controlled trial.

    Mehran R, Lansky AJ, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Wong SC, Nikolsky E, Gambone L, Vandertie L, Parise H, Dangas GD, Stone GW; HORIZONS-AMI Trial Investigators.

    Lancet. 2009 Oct 3;374(9696):1149-59. Epub 2009 Aug 28.PMID: 19717185 [PubMed - indexed for MEDLINE]Related articles

    3.

    Impact of chronic kidney disease on early (30-day) and late (1-year) outcomes of patients with acute coronary syndromes treated with alternative antithrombotic treatment strategies: an ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) substudy.

    Mehran R, Nikolsky E, Lansky AJ, Kirtane AJ, Kim YH, Feit F, Manoukian S, Moses JW, Ebrahimi R, Ohman EM, White HD, Pocock SJ, Dangas GD, Stone GW.

    JACC Cardiovasc Interv. 2009 Aug;2(8):748-57.PMID: 19695543 [PubMed - indexed for MEDLINE]Related articles

    4.

    Prognostic significance of periprocedural versus spontaneously occurring myocardial infarction after percutaneous coronary intervention in patients with acute coronary syndromes: an analysis from the ACUITY (Acute Catheterization and Urgent Intervention Triage Strategy) trial.

    Prasad A, Gersh BJ, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Pocock SJ, McLaurin BT, Cox DA, Lansky AJ, Mehran R, Stone GW.

    J Am Coll Cardiol. 2009 Jul 28;54(5):477-86.PMID: 19628125 [PubMed - indexed for MEDLINE]Related articles

    5.

    Insulin glargine and malignancy: an unwarranted alarm.

    Pocock SJ, Smeeth L.

    Lancet. 2009 Aug 15;374(9689):511-3. Epub 2009 Jul 17. No abstract available. PMID: 19616841 [PubMed - indexed for MEDLINE]Related articles

    6.

    Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial.

    Home PD, Pocock SJ, Beck-Nielsen H, Curtis PS, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Team.

    Lancet. 2009 Jun 20;373(9681):2125-35. Epub 2009 Jun 6.PMID: 19501900 [PubMed - indexed for MEDLINE]Related articles

    7.

    Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.

    Stone GW, Lansky AJ, Pocock SJ, Gersh BJ, Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Möckel M, Ochala A, Kellock A, Parise H, Mehran R; HORIZONS-AMI Trial Investigators.

    N Engl J Med. 2009 May 7;360(19):1946-59.PMID: 19420364 [PubMed - indexed for MEDLINE]Related articlesFree article

    8.

    Translating statistical findings into plain English.

    Pocock SJ, Ware JH.

    Lancet. 2009 Jun 6;373(9679):1926-8. Epub 2009 Apr 15. Review. No abstract available. PMID: 19375158 [PubMed - indexed for MEDLINE]Related articles

    9.

    Associations of major bleeding and myocardial infarction with the incidence and timing of mortality in patients presenting with non-ST-elevation acute coronary syndromes: a risk model from the ACUITY trial.

    Mehran R, Pocock SJ, Stone GW, Clayton TC, Dangas GD, Feit F, Manoukian SV, Nikolsky E, Lansky AJ, Kirtane A, White HD, Colombo A, Ware JH, Moses JW, Ohman EM.

    Eur Heart J. 2009 Jun;30(12):1457-66. Epub 2009 Apr 7.PMID: 19351691 [PubMed - indexed for MEDLINE]Related articles

    10.

    Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials.

    Hlatky MA, Boothroyd DB, Bravata DM, Boersma E, Booth J, Brooks MM, Carrié D, Clayton TC, Danchin N, Flather M, Hamm CW, Hueb WA, Kähler J, Kelsey SF, King SB, Kosinski AS, Lopes N, McDonald KM, Rodriguez A, Serruys P, Sigwart U, Stables RH, Owens DK, Pocock SJ.

    Lancet. 2009 Apr 4;373(9670):1190-7. Epub 2009 Mar 19.PMID: 19303634 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Strengthening the reporting of observational studies in epidemiology (STROBE): explanation and elaboration]

    Vandenbroucke JP, Von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; Iniciativa STROBE.

    Gac Sanit. 2009 Mar-Apr;23(2):158. Epub 2009 Feb 26. Spanish. PMID: 19249134 [PubMed - indexed for MEDLINE]Related articlesFree article

    12.

    Weight loss and mortality risk in patients with chronic heart failure in the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme.

    Pocock SJ, McMurray JJ, Dobson J, Yusuf S, Granger CB, Michelson EL, Ostergren J, Pfeffer MA, Solomon SD, Anker SD, Swedberg KB.

    Eur Heart J. 2008 Nov;29(21):2641-50. Epub 2008 Sep 26.PMID: 18819960 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Safety and efficacy of bivalirudin with and without glycoprotein IIb/IIIa inhibitors in patients with acute coronary syndromes undergoing percutaneous coronary intervention 1-year results from the ACUITY (Acute Catheterization and Urgent Intervention Triage strategY) trial.

    White HD, Ohman EM, Lincoff AM, Bertrand ME, Colombo A, McLaurin BT, Cox DA, Pocock SJ, Ware JA, Manoukian SV, Lansky AJ, Mehran R, Moses JW, Stone GW.

    J Am Coll Cardiol. 2008 Sep 2;52(10):807-14.PMID: 18755342 [PubMed - indexed for MEDLINE]Related articles

    14.

    [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies]

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; Iniciativa STROBE.

    Rev Esp Salud Publica. 2008 May-Jun;82(3):251-9. Spanish. PMID: 18711640 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    [The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting of observational studies]

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE-Initiative.

    Internist (Berl). 2008 Jun;49(6):688-93. German. PMID: 18511988 [PubMed - indexed for MEDLINE]Related articles

    16.

    Bivalirudin during primary PCI in acute myocardial infarction.

    Stone GW, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie BR, Dudek D, Kornowski R, Hartmann F, Gersh BJ, Pocock SJ, Dangas G, Wong SC, Kirtane AJ, Parise H, Mehran R; HORIZONS-AMI Trial Investigators.

    N Engl J Med. 2008 May 22;358(21):2218-30.PMID: 18499566 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    How to interpret figures in reports of clinical trials.

    Pocock SJ, Travison TG, Wruck LM.

    BMJ. 2008 May 24;336(7654):1166-9. Review. No abstract available. PMID: 18497415 [PubMed - indexed for MEDLINE]Related articles

    18.

    More on subgroup analyses in clinical trials.

    Pocock SJ, Lubsen J.

    N Engl J Med. 2008 May 8;358(19):2076; author reply 2076-7. No abstract available. PMID: 18463389 [PubMed - indexed for MEDLINE]Related articles

    19.

    Effect of the addition of rosiglitazone to metformin or sulfonylureas versus metformin/sulfonylurea combination therapy on ambulatory blood pressure in people with type 2 diabetes: a randomized controlled trial (the RECORD study).

    Komajda M, Curtis P, Hanefeld M, Beck-Nielsen H, Pocock SJ, Zambanini A, Jones NP, Gomis R, Home PD; RECORD Study Group.

    Cardiovasc Diabetol. 2008 Apr 24;7:10.PMID: 18435852 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    [The Strengthening the Reporting of Observational Studies in Epidemiology [STROBE] statement: guidelines for reporting observational studies]

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; Iniciativa STROBE.

    Gac Sanit. 2008 Mar-Apr;22(2):144-50. Spanish. Erratum in: Gac Sanit. 2008 Jul-Aug;22(4):391. PMID: 18420014 [PubMed - indexed for MEDLINE]Related articlesFree article

    21.

    The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative.

    J Clin Epidemiol. 2008 Apr;61(4):344-9.PMID: 18313558 [PubMed - indexed for MEDLINE]Related articles

    22.

    Angiographic surrogate end points in drug-eluting stent trials: a systematic evaluation based on individual patient data from 11 randomized, controlled trials.

    Pocock SJ, Lansky AJ, Mehran R, Popma JJ, Fahy MP, Na Y, Dangas G, Moses JW, Pucelikova T, Kandzari DE, Ellis SG, Leon MB, Stone GW.

    J Am Coll Cardiol. 2008 Jan 1;51(1):23-32.PMID: 18174032 [PubMed - indexed for MEDLINE]Related articles

    23.

    Safety of drug-eluting stents: demystifying network meta-analysis.

    Pocock SJ.

    Lancet. 2007 Dec 22;370(9605):2099-100. No abstract available. PMID: 18156025 [PubMed - indexed for MEDLINE]Related articles

    24.

    The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative.

    Lancet. 2007 Oct 20;370(9596):1453-7.PMID: 18064739 [PubMed - indexed for MEDLINE]Related articles

    25.

    Rosiglitazone increased heart failure but did not differ from metformin plus sulphonylurea for other CV outcomes at interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H.

    Evid Based Med. 2007 Dec;12(6):170. No abstract available. PMID: 18063730 [PubMed]Related articles

    26.

    Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.

    Stone GW, Ware JH, Bertrand ME, Lincoff AM, Moses JW, Ohman EM, White HD, Feit F, Colombo A, McLaurin BT, Cox DA, Manoukian SV, Fahy M, Clayton TC, Mehran R, Pocock SJ; ACUITY Investigators.

    JAMA. 2007 Dec 5;298(21):2497-506.PMID: 18056903 [PubMed - indexed for MEDLINE]Related articlesFree article

    27.

    Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

    Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative.

    Epidemiology. 2007 Nov;18(6):805-35.PMID: 18049195 [PubMed - indexed for MEDLINE]Related articles

    28.

    The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative.

    Epidemiology. 2007 Nov;18(6):800-4.PMID: 18049194 [PubMed - indexed for MEDLINE]Related articles

    29.

    The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative.

    Bull World Health Organ. 2007 Nov;85(11):867-72.PMID: 18038077 [PubMed - indexed for MEDLINE]Related articlesFree article

    30.

    The cost-effectiveness of an early interventional strategy in non-ST-elevation acute coronary syndrome based on the RITA 3 trial.

    Henriksson M, Epstein DM, Palmer SJ, Sculpher MJ, Clayton TC, Pocock SJ, Henderson RA, Buxton MJ, Fox KA.

    Heart. 2008 Jun;94(6):717-23. Epub 2007 Nov 21.PMID: 18032459 [PubMed - indexed for MEDLINE]Related articles

    31.

    Quality management of a large randomized double-blind multi-centre trial: the ACTION experience.

    Kirwan BA, Lubsen J, de Brouwer S, van Dalen FJ, Pocock SJ, Clayton T, Danchin N, Poole-Wilson PA; ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) investigators.

    Contemp Clin Trials. 2008 Mar;29(2):259-69. Epub 2007 Oct 13.PMID: 18029294 [PubMed - indexed for MEDLINE]Related articles

    32.

    Figures in clinical trial reports: current practice & scope for improvement.

    Pocock SJ, Travison TG, Wruck LM.

    Trials. 2007 Nov 19;8:36.PMID: 18021449 [PubMed - in process]Related articlesFree article

    33.

    The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative.

    Prev Med. 2007 Oct;45(4):247-51. Epub 2007 Sep 4. Review.PMID: 17950122 [PubMed - indexed for MEDLINE]Related articles

    34.

    Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative.

    BMJ. 2007 Oct 20;335(7624):806-8. No abstract available. PMID: 17947786 [PubMed - indexed for MEDLINE]Related articles

    35.

    Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

    Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE Initiative.

    PLoS Med. 2007 Oct 16;4(10):e297. Review.PMID: 17941715 [PubMed - indexed for MEDLINE]Related articlesFree article

    36.

    The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative.

    PLoS Med. 2007 Oct 16;4(10):e296. Review.PMID: 17941714 [PubMed - indexed for MEDLINE]Related articlesFree article

    37.

    The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

    von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP; STROBE Initiative.

    Ann Intern Med. 2007 Oct 16;147(8):573-7. Erratum in: Ann Intern Med. 2008 Jan 15;148(2):168. PMID: 17938396 [PubMed - indexed for MEDLINE]Related articlesFree article

    38.

    Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.

    Vandenbroucke JP, von Elm E, Altman DG, Gøtzsche PC, Mulrow CD, Pocock SJ, Poole C, Schlesselman JJ, Egger M; STROBE initiative.

    Ann Intern Med. 2007 Oct 16;147(8):W163-94.PMID: 17938389 [PubMed - indexed for MEDLINE]Related articlesFree article

    39.

    Costs of an early intervention versus a conservative strategy in acute coronary syndrome.

    Epstein DM, Sculpher MJ, Clayton TC, Henderson RA, Pocock SJ, Buxton MJ, Fox KA.

    Int J Cardiol. 2008 Jul 4;127(2):240-6. Epub 2007 Aug 16.PMID: 17707103 [PubMed - indexed for MEDLINE]Related articles

    40.

    Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program.

    Kenchaiah S, Pocock SJ, Wang D, Finn PV, Zornoff LA, Skali H, Pfeffer MA, Yusuf S, Swedberg K, Michelson EL, Granger CB, McMurray JJ, Solomon SD; CHARM Investigators.

    Circulation. 2007 Aug 7;116(6):627-36. Epub 2007 Jul 16. Erratum in: Circulation. 2007 Aug 7;116(6):e136. PMID: 17638930 [PubMed - indexed for MEDLINE]Related articlesFree article

    41.

    Red cell distribution width as a novel prognostic marker in heart failure: data from the CHARM Program and the Duke Databank.

    Felker GM, Allen LA, Pocock SJ, Shaw LK, McMurray JJ, Pfeffer MA, Swedberg K, Wang D, Yusuf S, Michelson EL, Granger CB; CHARM Investigators.

    J Am Coll Cardiol. 2007 Jul 3;50(1):40-7. Epub 2007 Jun 18.PMID: 17601544 [PubMed - indexed for MEDLINE]Related articles

    42.

    Development and validation of a prognostic risk score for major bleeding in patients undergoing percutaneous coronary intervention via the femoral approach.

    Nikolsky E, Mehran R, Dangas G, Fahy M, Na Y, Pocock SJ, Lincoff AM, Stone GW.

    Eur Heart J. 2007 Aug;28(16):1936-45. Epub 2007 Jun 15.PMID: 17575270 [PubMed - indexed for MEDLINE]Related articlesFree article

    43.

    Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

    Home PD, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Jones NP, Komajda M, McMurray JJ; RECORD Study Group.

    N Engl J Med. 2007 Jul 5;357(1):28-38. Epub 2007 Jun 5.PMID: 17551159 [PubMed - indexed for MEDLINE]Related articlesFree article

    44.

    Rosiglitazone RECORD study: glucose control outcomes at 18 months.

    Home PD, Jones NP, Pocock SJ, Beck-Nielsen H, Gomis R, Hanefeld M, Komajda M, Curtis P; RECORD Study Group.

    Diabet Med. 2007 Jun;24(6):626-34.PMID: 17517066 [PubMed - indexed for MEDLINE]Related articlesFree article

    45.

    Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

    Mebazaa A, Nieminen MS, Packer M, Cohen-Solal A, Kleber FX, Pocock SJ, Thakkar R, Padley RJ, Põder P, Kivikko M; SURVIVE Investigators.

    JAMA. 2007 May 2;297(17):1883-91.PMID: 17473298 [PubMed - indexed for MEDLINE]Related articlesFree article

    46.

    Bivalirudin in patients with acute coronary syndromes undergoing percutaneous coronary intervention: a subgroup analysis from the Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial.

    Stone GW, White HD, Ohman EM, Bertrand ME, Lincoff AM, McLaurin BT, Cox DA, Pocock SJ, Ware JH, Feit F, Colombo A, Manoukian SV, Lansky AJ, Mehran R, Moses JW; Acute Catheterization and Urgent Intervention Triage strategy (ACUITY) trial investigators.

    Lancet. 2007 Mar 17;369(9565):907-19.PMID: 17368152 [PubMed - indexed for MEDLINE]Related articles

    47.

    Prevalence and prognostic impact of bundle branch block in patients with heart failure: evidence from the CHARM programme.

    Hawkins NM, Wang D, McMurray JJ, Pfeffer MA, Swedberg K, Granger CB, Yusuf S, Pocock SJ, Ostergren J, Michelson EL, Dunn FG; CHARM Investigators and Committees.

    Eur J Heart Fail. 2007 May;9(5):510-7. Epub 2007 Feb 20.PMID: 17317308 [PubMed - indexed for MEDLINE]Related articles

    48.

    Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.

    Stone GW, Bertrand ME, Moses JW, Ohman EM, Lincoff AM, Ware JH, Pocock SJ, McLaurin BT, Cox DA, Jafar MZ, Chandna H, Hartmann F, Leisch F, Strasser RH, Desaga M, Stuckey TD, Zelman RB, Lieber IH, Cohen DJ, Mehran R, White HD; ACUITY Investigators.

    JAMA. 2007 Feb 14;297(6):591-602.PMID: 17299194 [PubMed - indexed for MEDLINE]Related articlesFree article

    49.

    Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents.

    Stone GW, Moses JW, Ellis SG, Schofer J, Dawkins KD, Morice MC, Colombo A, Schampaert E, Grube E, Kirtane AJ, Cutlip DE, Fahy M, Pocock SJ, Mehran R, Leon MB.

    N Engl J Med. 2007 Mar 8;356(10):998-1008. Epub 2007 Feb 12.PMID: 17296824 [PubMed - indexed for MEDLINE]Related articlesFree article

    50.

    Current controversies in data monitoring for clinical trials.

    Pocock SJ.

    Clin Trials. 2006;3(6):513-21.PMID: 17170035 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data

    Search details

    » See more...